Anyone concerned MPH shares have reached multi-year lows??over 3 years to be exact. I'm starting to think the only one buying shares is the company itself. In regards to the statin market, you have to realize not only it is extremely crowded, there are a wide variety of inexpensive generics on the market. Profit potential is limited. Long-time holder here and I've been slowly liquidating my position because I don't see any long-term potential in Medicure.